What's new in DyslipidemiaLast update of the site: Tuesday September 20, 2022

Gitto, Mauro MD et al. | Journal of Cardiovascular Pharmacology...
Type 2 diabetes mellitus is a leading cause of morbidity and mortality worldwide, affecting nearly 10%...
Akilli, Rabia MD et al. | Menopause 2022; 29(8): 905-10
Atherosclerotic cardiovascular disease (ASCVD) is the most common cause of death in postmenopausal women.1,2...
Oggero, Silvia et al. | Journal of Hypertension 2022; 40(8):...
Extracellular vesicles have been proposed as potential biomarkers of cardiovascular risk [1-3]. Compared...
Faletra Agostino et al. | BMC Musculoskeletal Disorders 2022;...
Patients with musculoskeletal disorders frequently present with significant cardiovascular risk factors...
Georgakis Marios K. et al. | BMC Medicine 2022; 20(1): 245
Chronic inflammation is an emerging therapeutic target for cardiovascular disease (CVD) [1]. Among pharmacological...
Maria Maddalena D'Errico et al. | European Journal of Clinical Investigation...
The CHADS score was introduced in 2006 by the ACC/AHA/ESC guidelines for the management of patients with...
Yun Jae-Seung et al. | Cardiovascular Diabetology 2022; 21(1):...
Cardiovascular disease (CVD) is one of the leading causes of mortality, and has become a global public...
Dongxue Zhang et al. | Journal of Periodontal Research 2022;...
According to the International Diabetes Federation, in 2015, an estimated 415 million people were...
Faizan Mazhar PharmD et al. | Journal of the American Heart Association...
Both adherence and treatment intensity can alter the effectiveness of lipid‐lowering therapy (LLT)...
Louisa Bloudeau et al. | Pediatric Nephrology 2022; aop: 10.1007/s00467-022-05636-9...
X-linked hypophosphatemia (XLH) is an orphan genetic disease most commonly associated with an inactivating...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
839 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Maria Maddalena D'Errico et al. | European Journal of Clinical Investigation...
The CHADS score was introduced in 2006 by the ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation (AF) as a clinical predictive measure to estimate the cardioembolic risk in...
Gitto, Mauro MD et al. | Journal of Cardiovascular Pharmacology...
Type 2 diabetes mellitus is a leading cause of morbidity and mortality worldwide, affecting nearly 10% of adults in high-income countries.1 Cardiovascular diseases are a major prognostic determinant in...
Faizan Mazhar PharmD et al. | Journal of the American Heart Association...
Both adherence and treatment intensity can alter the effectiveness of lipid‐lowering therapy (LLT) in routine clinical practice; suboptimal LLT management may affect cardiovascular disease recurrence...
Yun Jae-Seung et al. | Cardiovascular Diabetology 2022; 21(1):...
Cardiovascular disease (CVD) is one of the leading causes of mortality, and has become a global public health concern [1]. As such, it is of particular importance to document cardiovascular (CV) risk factors...
Georgakis Marios K. et al. | BMC Medicine 2022; 20(1): 245
Chronic inflammation is an emerging therapeutic target for cardiovascular disease (CVD) [1]. Among pharmacological candidates, agents impacting interleukin (IL)-6 signaling have attracted attention due...